Skip to main content
Top
Published in: Current Obesity Reports 2/2019

01-06-2019 | Obesity | Psychological Issues (V Drapeau and V Ivezaj, Section Editors)

Primary Care Interventions for Obesity: Review of the Evidence

Authors: Jena Shaw Tronieri, Thomas A. Wadden, Ariana M. Chao, Adam Gilden Tsai

Published in: Current Obesity Reports | Issue 2/2019

Login to get access

Abstract

Purpose of Review

This review describes the results of randomized controlled trials that have evaluated the efficacy of behavioral interventions for obesity in primary care settings.

Recent Findings

Most studies have found that high-intensity behavioral counseling (providing 12 or more sessions per year, as defined by the US Preventative Services Task Force), when delivered in-person, by phone, or electronically, produced clinically meaningful weight loss (4 to 7 kg). Low- to moderate-intensity behavioral counseling and counseling that did not include behavioral strategies (e.g., motivational interviewing) produced modest losses of 1 to 2 kg. The addition of weight loss medication increased mean losses relative to behavioral treatment alone.

Summary

Consistent with national guidelines, the largest weight losses were achieved with high-intensity counseling, either alone or in combination with obesity pharmacotherapy. Primary care providers can support their patients by inviting them to discuss their weight concerns and referring interested individuals to appropriate interventions.
Literature
2.
go back to reference Hales C, Carroll M, Fryar C, Ogden C. Prevalence of obesity among adults and youth: United States, 2015–2016 NCHS data brief, no 288 2017;288. Hales C, Carroll M, Fryar C, Ogden C. Prevalence of obesity among adults and youth: United States, 2015–2016 NCHS data brief, no 288 2017;288.
3.
go back to reference Curry S, Krist A, Owens D, Barry M, Caughey A, Davidson K, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(11):1163–71.CrossRef Curry S, Krist A, Owens D, Barry M, Caughey A, Davidson K, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(11):1163–71.CrossRef
4.
go back to reference Mctigue KM, Harris R, Hemphill B, Lux L. Screening for obesity in adults: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(11):I–57.CrossRef Mctigue KM, Harris R, Hemphill B, Lux L. Screening for obesity in adults: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. 2003;139(11):I–57.CrossRef
5.
go back to reference Moyer VA, U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):373–8.PubMed Moyer VA, U.S. Preventive Services Task Force. Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):373–8.PubMed
6.
go back to reference United States Congress. Patient protection and affordable care act (PPACA), section 2713. 2010. United States Congress. Patient protection and affordable care act (PPACA), section 2713. 2010.
7.
go back to reference Centers for Medicare & Medicaid Services. Decision memo for intensive behavioral therapy for obesity (CAG-00423N). 2011. Centers for Medicare & Medicaid Services. Decision memo for intensive behavioral therapy for obesity (CAG-00423N). 2011.
8.
go back to reference Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRef Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 Pt B):2985–3023.CrossRef
9.
go back to reference Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metabolism. 2015;100(2):342–62.CrossRef Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline. J Clin Endocrinol Metabolism. 2015;100(2):342–62.CrossRef
10.
go back to reference • Fitzpatrick SL, Stevens VJ. Adult obesity management in primary care, 2008–2013. Prev Med. 2017;99:128–33 Study showing a decline in the diagnosis and treatment of obesity in primary care between 2008–2009 and 2012–2013. CrossRef • Fitzpatrick SL, Stevens VJ. Adult obesity management in primary care, 2008–2013. Prev Med. 2017;99:128–33 Study showing a decline in the diagnosis and treatment of obesity in primary care between 2008–2009 and 2012–2013. CrossRef
11.
go back to reference Rui P, Okeyode T. National Ambulatory Medical Care Survey: 2015 State and National Summary Tables. Rui P, Okeyode T. National Ambulatory Medical Care Survey: 2015 State and National Summary Tables.
12.
go back to reference •• LeBlanc E, Patnode C, Webber E, Redmond N, Rushkin M, O’Connor E. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(11):1172–91 Updated systematic review of primary care-relevant studies by the USPSTF. CrossRef •• LeBlanc E, Patnode C, Webber E, Redmond N, Rushkin M, O’Connor E. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(11):1172–91 Updated systematic review of primary care-relevant studies by the USPSTF. CrossRef
13.
go back to reference Wadden TA, Butryn ML, Hong PS, Tsai AG. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312(17):1779–91.CrossRef Wadden TA, Butryn ML, Hong PS, Tsai AG. Behavioral treatment of obesity in patients encountered in primary care settings: a systematic review. JAMA. 2014;312(17):1779–91.CrossRef
14.
go back to reference le Blanc ES, O’Connor E, Whitlock EP, Patnode CD, Kapka T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(7):434–47.CrossRef le Blanc ES, O’Connor E, Whitlock EP, Patnode CD, Kapka T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(7):434–47.CrossRef
15.
go back to reference Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–66.CrossRef Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–66.CrossRef
16.
go back to reference Appel LJ, Clark JM, Yeh H, Wang N, Coughlin JW, Daumit G, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365(21):1959–68.CrossRef Appel LJ, Clark JM, Yeh H, Wang N, Coughlin JW, Daumit G, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med. 2011;365(21):1959–68.CrossRef
17.
go back to reference Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med. 2011;365(21):1969–79.CrossRef Wadden TA, Volger S, Sarwer DB, Vetter ML, Tsai AG, Berkowitz RI, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med. 2011;365(21):1969–79.CrossRef
18.
go back to reference Kumanyika SK, Fassbender JE, Sarwer DB, Phipps E, Allison KC, Localio R, et al. One-year results of the think health study of weight management in primary care practices. Obesity. 2012;20(6):1249–57.CrossRef Kumanyika SK, Fassbender JE, Sarwer DB, Phipps E, Allison KC, Localio R, et al. One-year results of the think health study of weight management in primary care practices. Obesity. 2012;20(6):1249–57.CrossRef
19.
go back to reference Kumanyika SK, Morales KH, Allison KC, Russell Localio A, Sarwer DB, Phipps E, et al. Two-year results of think health! ¡vive Saludable!: a primary care weight-management trial: think health! Primary care trial 2-year results. Obesity. 2018;26(9):1412–21.CrossRef Kumanyika SK, Morales KH, Allison KC, Russell Localio A, Sarwer DB, Phipps E, et al. Two-year results of think health! ¡vive Saludable!: a primary care weight-management trial: think health! Primary care trial 2-year results. Obesity. 2018;26(9):1412–21.CrossRef
20.
go back to reference • Wadden TA, Walsh OA, Berkowitz RI, Chao AM, Alamuddin N, Gruber KA, et al. Intensive behavioral therapy for obesity combined with liraglutide 3.0 mg: a randomized controlled trial. Obesity. 2019;27(1):75–86 First study to employ primary care providers to deliver a structured behavioral treatment using the visit schedule covered by CMS (21, 15-min individual sessions over 1 year). CrossRef • Wadden TA, Walsh OA, Berkowitz RI, Chao AM, Alamuddin N, Gruber KA, et al. Intensive behavioral therapy for obesity combined with liraglutide 3.0 mg: a randomized controlled trial. Obesity. 2019;27(1):75–86 First study to employ primary care providers to deliver a structured behavioral treatment using the visit schedule covered by CMS (21, 15-min individual sessions over 1 year). CrossRef
21.
go back to reference Bennett GG, Warner ET, Glasgow RE, Askew S, Goldman J, Ritzwoller DP, et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012;172(7):565–74.CrossRef Bennett GG, Warner ET, Glasgow RE, Askew S, Goldman J, Ritzwoller DP, et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012;172(7):565–74.CrossRef
22.
go back to reference Bennett GG, Steinberg D, Askew S, Levine E, Foley P, Batch BC, et al. Effectiveness of an app and provider counseling for obesity treatment in primary care. Am J Prev Med. 2018;55(6):777–86.CrossRef Bennett GG, Steinberg D, Askew S, Levine E, Foley P, Batch BC, et al. Effectiveness of an app and provider counseling for obesity treatment in primary care. Am J Prev Med. 2018;55(6):777–86.CrossRef
23.
go back to reference Weinstock RS, Trief PM, Cibula D, Morin PC, Delahanty LM. Weight loss success in metabolic syndrome by telephone interventions: results from the SHINE study. J Gen Intern Med. 2013;28(12):1620–8.CrossRef Weinstock RS, Trief PM, Cibula D, Morin PC, Delahanty LM. Weight loss success in metabolic syndrome by telephone interventions: results from the SHINE study. J Gen Intern Med. 2013;28(12):1620–8.CrossRef
24.
go back to reference Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, Rosas LG, et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173(2):113–21.CrossRef Ma J, Yank V, Xiao L, Lavori PW, Wilson SR, Rosas LG, et al. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. JAMA Intern Med. 2013;173(2):113–21.CrossRef
25.
go back to reference Xiao L, Yank V, Wilson SR, Lavori PW, Ma J. Two-year weight-loss maintenance in primary care-based diabetes prevention program lifestyle interventions. Nutri Diabetes. 2013;3(6):e76.CrossRef Xiao L, Yank V, Wilson SR, Lavori PW, Ma J. Two-year weight-loss maintenance in primary care-based diabetes prevention program lifestyle interventions. Nutri Diabetes. 2013;3(6):e76.CrossRef
26.
go back to reference Tsai AG, Felton S, Wadden TA, Hosokawa PW, Hill JO. A randomized clinical trial of a weight loss maintenance intervention in a primary care population. Obesity. 2015;23(10):2015–21.CrossRef Tsai AG, Felton S, Wadden TA, Hosokawa PW, Hill JO. A randomized clinical trial of a weight loss maintenance intervention in a primary care population. Obesity. 2015;23(10):2015–21.CrossRef
27.
go back to reference Sherrington A, Newham JJ, Bell R, Adamson A, McColl E, Araujo-Soares V. Systematic review and meta-analysis of internet-delivered interventions providing personalized feedback for weight loss in overweight and obese adults. Obes Rev. 2016;17(6):541–51.CrossRef Sherrington A, Newham JJ, Bell R, Adamson A, McColl E, Araujo-Soares V. Systematic review and meta-analysis of internet-delivered interventions providing personalized feedback for weight loss in overweight and obese adults. Obes Rev. 2016;17(6):541–51.CrossRef
28.
go back to reference Tate D, Nezami B, Valle C. Remotely delivered interventions for obesity. In: Wadden TA, Bray GA, editors. Handbook of obesity treatment. 2nd ed: Guilford Press; 2018. p. 466–79. Tate D, Nezami B, Valle C. Remotely delivered interventions for obesity. In: Wadden TA, Bray GA, editors. Handbook of obesity treatment. 2nd ed: Guilford Press; 2018. p. 466–79.
29.
go back to reference • Thomas G, Leahey TM, Wing RR. An automated internet behavioral weight-loss program by physician referral: a randomized controlled trial. Diabetes Care. 2015;38(1):9–15 First study to test a fully automated internet behavioral weight-loss program in primary care. CrossRef • Thomas G, Leahey TM, Wing RR. An automated internet behavioral weight-loss program by physician referral: a randomized controlled trial. Diabetes Care. 2015;38(1):9–15 First study to test a fully automated internet behavioral weight-loss program in primary care. CrossRef
30.
go back to reference Pagoto S, Schneider K, Jojic M, DeBiasse M, Mann D. Evidence-based strategies in weight-loss mobile apps. Am J Prev Med 2013. 2013;45(5):576–82.CrossRef Pagoto S, Schneider K, Jojic M, DeBiasse M, Mann D. Evidence-based strategies in weight-loss mobile apps. Am J Prev Med 2013. 2013;45(5):576–82.CrossRef
31.
go back to reference Laing B, Mangione C, Tseng C, Leng M, Vaisberg E, Mahida M, et al. Effectiveness of a smartphone application for weight loss compared with usual care in overweight primary care patients: a randomized, controlled trial. Ann Intern Med. 2014;161(10):S5–S12.CrossRef Laing B, Mangione C, Tseng C, Leng M, Vaisberg E, Mahida M, et al. Effectiveness of a smartphone application for weight loss compared with usual care in overweight primary care patients: a randomized, controlled trial. Ann Intern Med. 2014;161(10):S5–S12.CrossRef
32.
go back to reference Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, Bock BC. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Am J Health Promot. 2008. Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, Bock BC. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Am J Health Promot. 2008.
33.
go back to reference Christian JG, Byers TE, Christian KK, Goldstein MG, Bock BC, Prioreschi B, et al. A computer support program that helps clinicians provide patients with metabolic syndrome tailored counseling to promote weight loss. J Am Diet Assoc. 2011;111(1):75–83.CrossRef Christian JG, Byers TE, Christian KK, Goldstein MG, Bock BC, Prioreschi B, et al. A computer support program that helps clinicians provide patients with metabolic syndrome tailored counseling to promote weight loss. J Am Diet Assoc. 2011;111(1):75–83.CrossRef
34.
go back to reference Miller WR, Rollnick S. Motivational interviewing: helping people change. Guilford press; 2012. Miller WR, Rollnick S. Motivational interviewing: helping people change. Guilford press; 2012.
35.
go back to reference Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.CrossRef Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.CrossRef
36.
go back to reference Barnes R, Ivezaj V. A systematic review of motivational interviewing for weight loss among adults in primary care. Obes Rev. 2015;16(4):304–18.CrossRef Barnes R, Ivezaj V. A systematic review of motivational interviewing for weight loss among adults in primary care. Obes Rev. 2015;16(4):304–18.CrossRef
37.
go back to reference Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.CrossRef Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.CrossRef
38.
go back to reference Stunkard A, Craighead LW, O'Brien R. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet. 1980;316(8203):1045–7.CrossRef Stunkard A, Craighead LW, O'Brien R. Controlled trial of behaviour therapy, pharmacotherapy, and their combination in the treatment of obesity. Lancet. 1980;316(8203):1045–7.CrossRef
39.
go back to reference Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 2001;161(2):218–27.CrossRef Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 2001;161(2):218–27.CrossRef
40.
go back to reference Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111–20.CrossRef Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111–20.CrossRef
41.
go back to reference Digenio AG, Mancuso JP, Gerber RA, Dvorak RV. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med. 2009;150(4):255–62.CrossRef Digenio AG, Mancuso JP, Gerber RA, Dvorak RV. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med. 2009;150(4):255–62.CrossRef
42.
go back to reference Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347(7931):f5934.CrossRef Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;347(7931):f5934.CrossRef
43.
go back to reference Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Anau J, et al. Comparative effectiveness and safety of bariatric procedures for weight loss. Ann Intern Med. 2018;169:741–50.CrossRef Arterburn D, Wellman R, Emiliano A, Smith SR, Odegaard AO, Anau J, et al. Comparative effectiveness and safety of bariatric procedures for weight loss. Ann Intern Med. 2018;169:741–50.CrossRef
44.
go back to reference Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.CrossRef Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445–54.CrossRef
45.
go back to reference Kushner R. What do we need to do to get primary care ready to treat obesity? Obesity. 2018 Apr;26(4):631–2.CrossRef Kushner R. What do we need to do to get primary care ready to treat obesity? Obesity. 2018 Apr;26(4):631–2.CrossRef
46.
go back to reference Rutledge T, Groesz L, Linke S, Woods G, Herbst K. Behavioural weight management for the primary careprovider. Obes Rev. 2011;12(5):e290–7.CrossRef Rutledge T, Groesz L, Linke S, Woods G, Herbst K. Behavioural weight management for the primary careprovider. Obes Rev. 2011;12(5):e290–7.CrossRef
47.
go back to reference Post RE, Mainous AG, Gregorie SH, Knoll ME, Diaz VA, Saxena SK. The influence of physician acknowledgment of patients’ weight status on patient perceptions of overweight and obesity in the United States. Arch Intern Med. 2011;171(4):316–21.CrossRef Post RE, Mainous AG, Gregorie SH, Knoll ME, Diaz VA, Saxena SK. The influence of physician acknowledgment of patients’ weight status on patient perceptions of overweight and obesity in the United States. Arch Intern Med. 2011;171(4):316–21.CrossRef
48.
go back to reference Aveyard P, Lewis A, Tearne S, Hood K, Christian-Brown A, Adab P, et al. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Lancet. 2016;388(10059):2492–500.CrossRef Aveyard P, Lewis A, Tearne S, Hood K, Christian-Brown A, Adab P, et al. Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial. Lancet. 2016;388(10059):2492–500.CrossRef
49.
go back to reference Wadden TA, Anderson DA, Foster GD, Bennett A, Steinberg C, Sarwer DB. Obese women’s perceptions of their physicians’ weight management attitudes and practices. Arch Fam Med. 2000;9(9):854–60.CrossRef Wadden TA, Anderson DA, Foster GD, Bennett A, Steinberg C, Sarwer DB. Obese women’s perceptions of their physicians’ weight management attitudes and practices. Arch Fam Med. 2000;9(9):854–60.CrossRef
50.
go back to reference Volger S, Vetter ML, Dougherty M, Panigrahi E, Egner R, Webb V, et al. Patients’ preferred terms for describing their excess weight: discussing obesity in clinical practice. Obesity. 2012;20(1):147–50.CrossRef Volger S, Vetter ML, Dougherty M, Panigrahi E, Egner R, Webb V, et al. Patients’ preferred terms for describing their excess weight: discussing obesity in clinical practice. Obesity. 2012;20(1):147–50.CrossRef
51.
go back to reference Wadden TA, Didie E. What’s in a name? Patients' preferred terms for describing obesity. Obes Res. 2003;11(9):1140–6.CrossRef Wadden TA, Didie E. What’s in a name? Patients' preferred terms for describing obesity. Obes Res. 2003;11(9):1140–6.CrossRef
52.
go back to reference Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162(7):501–12.CrossRef Gudzune KA, Doshi RS, Mehta AK, Chaudhry ZW, Jacobs DK, Vakil RM, et al. Efficacy of commercial weight-loss programs: an updated systematic review. Ann Intern Med. 2015;162(7):501–12.CrossRef
53.
go back to reference Gudzune KA, Clark JM. Commercial weight-loss programs. In: Wadden TA, Bray GA, editors. Handbook of obesity treatment. 2nd ed: Guilford Press; 2018. p. 480. Gudzune KA, Clark JM. Commercial weight-loss programs. In: Wadden TA, Bray GA, editors. Handbook of obesity treatment. 2nd ed: Guilford Press; 2018. p. 480.
54.
go back to reference Mitchell NS, Dickinson LM, Kempe A, Tsai AG. Determining the effectiveness of Take Off Pounds Sensibly (TOPS), a nationally available nonprofit weight loss program. Obesity. 2011;19(3):568–73.CrossRef Mitchell NS, Dickinson LM, Kempe A, Tsai AG. Determining the effectiveness of Take Off Pounds Sensibly (TOPS), a nationally available nonprofit weight loss program. Obesity. 2011;19(3):568–73.CrossRef
55.
go back to reference Fairburn CG. Overcoming binge eating: the proven program to learn why you binge and how you can stop. 2nd ed. New York: The Guilford Press; 2013. Fairburn CG. Overcoming binge eating: the proven program to learn why you binge and how you can stop. 2nd ed. New York: The Guilford Press; 2013.
56.
go back to reference Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients’ expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997;65(1):79–85.CrossRef Foster GD, Wadden TA, Vogt RA, Brewer G. What is a reasonable weight loss? Patients’ expectations and evaluations of obesity treatment outcomes. J Consult Clin Psychol. 1997;65(1):79–85.CrossRef
57.
go back to reference Wadden TA, Womble LG, Sarwer DB, Berkowitz RI, Clark VL, Foster GD. Great expectations: “I’m losing 25% of my weight no matter what you say”. J Consult Clin Psychol. 2003;71(6):1084–9.CrossRef Wadden TA, Womble LG, Sarwer DB, Berkowitz RI, Clark VL, Foster GD. Great expectations: “I’m losing 25% of my weight no matter what you say”. J Consult Clin Psychol. 2003;71(6):1084–9.CrossRef
58.
go back to reference Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–6.CrossRef Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481–6.CrossRef
59.
go back to reference Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364(13):1218–29.CrossRef Villareal DT, Chode S, Parimi N, Sinacore DR, Hilton T, Armamento-Villareal R, et al. Weight loss, exercise, or both and physical function in obese older adults. N Engl J Med. 2011;364(13):1218–29.CrossRef
60.
go back to reference Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008;88(4):906–12.CrossRef Rosenbaum M, Hirsch J, Gallagher DA, Leibel RL. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr. 2008;88(4):906–12.CrossRef
61.
go back to reference Fothergill E, Guo J, Howard L, Kerns J, Knuth N, Brychta R, et al. Persistent metabolic adaptation 6 years after “the biggest loser” competition. Obesity. 2016;24(8):1612–9.CrossRef Fothergill E, Guo J, Howard L, Kerns J, Knuth N, Brychta R, et al. Persistent metabolic adaptation 6 years after “the biggest loser” competition. Obesity. 2016;24(8):1612–9.CrossRef
62.
go back to reference Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.CrossRef Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.CrossRef
63.
go back to reference Wang G, Tomasi D, Volkow N, Wang R, Telang F, Caparelli E, et al. Effect of combined naltrexone and bupropion therapy on the brain’s reactivity to food cues. Int J Obes. 2014;38(5):682–8.CrossRef Wang G, Tomasi D, Volkow N, Wang R, Telang F, Caparelli E, et al. Effect of combined naltrexone and bupropion therapy on the brain’s reactivity to food cues. Int J Obes. 2014;38(5):682–8.CrossRef
64.
go back to reference Tronieri JS, Wadden TA, Walsh OA, Berkowitz RI, Alamuddin N, Gruber KA, et al. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J Obes. In press. Tronieri JS, Wadden TA, Walsh OA, Berkowitz RI, Alamuddin N, Gruber KA, et al. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J Obes. In press.
Metadata
Title
Primary Care Interventions for Obesity: Review of the Evidence
Authors
Jena Shaw Tronieri
Thomas A. Wadden
Ariana M. Chao
Adam Gilden Tsai
Publication date
01-06-2019
Publisher
Springer US
Published in
Current Obesity Reports / Issue 2/2019
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-019-00341-5

Other articles of this Issue 2/2019

Current Obesity Reports 2/2019 Go to the issue

Obesity Treatment (CM Apovian, Section Editor)

Metformin: Mechanisms in Human Obesity and Weight Loss

Psychological Issues (V Drapeau and V Ivezaj, Section Editors)

The Influence of Parental Dieting Behavior on Child Dieting Behavior and Weight Status

Psychological Issues (V Drapeau and V Ivezaj, Section Editors)

A Review of the Relationship between Night Eating Syndrome and Body Mass Index

Obesity Treatment (CM Apovian, Section Editor)

Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation